Table 1.
Demographic and baseline clinical characteristics of CIS patients and controls
| Characteristics | CIS | HD |
|---|---|---|
| n | 147 | 50 |
| Age (years) | 29.5 (7.3) | 29.9 (6.0) |
| Female/male (% women) | 110/37 (75.5) | 38/12 (76.0) |
| Follow-up (years)a | 7.0 (2.8–12.5) | - |
| Oligoclonal bands (% positive)* | 93 (65.5) | - |
| Clinical presentation [n (%)] | - | |
| Optic neuritis | 66 (44.9) | - |
| Spinal | 34 (23.1) | - |
| Brainstem | 33 (22.4) | - |
| Others | 14 (9.5) | - |
| Number of Barkhof criteria [n (%)] | ||
| 0 | 54 (37.0) | - |
| 1–2 | 39 (26.7) | - |
| 3–4 | 53 (36.3) | - |
Data are expressed as mean (standard deviation) unless otherwise stated.
a
Data are expressed as mean (range).
*
Oligoclonal bands were not available in 5 patients. CIS: patients with clinically isolated syndromes. HD: healthy donors